Medicine & Health

New research from engineers at Washington University unlocks the power of exceptional points for advanced optical sensing.

Pulse oximeters may provide inaccurate readings in individuals with darker skin so researchers at Washington University are seeking ways to mitigate this potential bias.

A sleep apnea treatment known as hypoglossal nerve stimulation is less effective in people with higher body mass indexes, according to a new study by researchers at the School of Medicine.

Washington University researcher Hong Chen and her team developed a quality assurance protocol to ensure their guided focused ultrasound device and treatment functions safely and consistently.

Researchers at Washington University School of Medicine in St. Louis have found a different and promising way to remove amyloid beta plaques in the brain: by directly mobilizing immune cells to consume them. The study was published in Science Translational Medicine.

A clinical trial led by researchers at Washington University School of Medicine in St. Louis is aimed at defining how exercise affects cardiovascular health in people who use wheelchairs.

Matthew Bersi, at the McKelvey School of Engineering, will use pioneering optics-based mechanical testing and imaging techniques to study the aorta with a five-year $575,000 CAREER award from the National Science Foundation.

Janine Bijsterbosch, an assistant professor of radiology at the School of Medicine, is part of a team of five co-principal investigators studying how symptoms of depression, anxiety and stress — together known as anxious misery — affect functional brain networks. The team received a $3.6 million grant from the National Institute of Mental Health.

As universities around the world strive to cultivate diverse and equitable communities, a recent study from the Brown School at Washington University in St. Louis highlights the necessity of recognizing age as a fundamental dimension of diversity.

New research at the School of Medicine bolsters previous findings that “polypills” — single pills that combine medications that target cardiovascular disease-related conditions — are beneficial in preventing heart attacks and strokes and reducing deaths. As a result of the study, the World Health Organization has added such polypills to its most recent Model List of Essential Medicines.